SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-025949
Filing Date
2022-05-12
Accepted
2022-05-12 16:15:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT NO. 1 ea159804-424b3_jasperthera.htm 424B3 1184535
2 GRAPHIC image_001.jpg GRAPHIC 2860
  Complete submission text file 0001213900-22-025949.txt   1189711
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260306 | Film No.: 22917994
SIC: 2836 Biological Products, (No Diagnostic Substances)